FDA.reportPublic FDA data

clindamycin 2 % Vaginal Gel

RxCUI
2587810
RxNorm name
clindamycin 2 % Vaginal Gel
Display name
clindamycin 2 % Vaginal Gel
Full name
clindamycin 2 % Vaginal Gel
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
XACIATOCLINDAMYCIN PHOSPHATEOrganon LLC0423007f-28fa-4159-bf58-9174626d23472026-02-19Warnings, Adverse reactionsExact identifier
rxcui: 2587810

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0423007f-28fa-4159-bf58-9174626d2347clindamycin phosphate 2 % Vaginal Gel [PSN] · clindamycin 0.02 MG/MG Vaginal Gel [SCD] · clindamycin (as clindamycin phosphate) 2 % Vaginal Gel [SY] · clindamycin 2 % Vaginal Gel [SY]413These highlights do not include all the information needed to use XACIATO safely and effectively. See full prescribing information for XACIATO XACIATO ® (clindamycin phosphate) vaginal gel Initial U.S. Approval: 202120260219